Kurşun asetat maruziyetine bağlı gelişen mide hasarında naringinin visfatin ve TNF-α immunreaktivitesi üzerinden potansiyel koruyucu etkilerinin belirlenmesi

Öz

Amaç: Bu çalışma, güçlü antioksidan ve antiinflamatuvar özelliklere sahip doğal bir flavonoid olan naringinin, kurşun asetatın neden olduğu gastrik mukozal hasara karşı koruyucu etkilerini araştırmayı amaçlamıştır. Kurşun toksisitesi, mide mukozasında oksidatif stres ve inflamatuvar yanıtı artırarak morfolojik bütünlüğü bozmaktadır. Bu nedenle, naringinin bu patolojik süreç üzerindeki potansiyel düzenleyici rolü değerlendirilmiştir. Yöntem: Toplam 28 erkek Wistar albino sıçan dört gruba ayrılmıştır: kontrol, naringin (40 mg/kg), kurşun asetat (500 ppm) ve kurşun asetat+naringin. Uygulamalar 30 gün boyunca orogastrik gavaj ve içme suyu yoluyla gerçekleştirilmiştir. Deney sonunda elde edilen mide dokuları Hematoksilen–Eozin (H&E) boyası ile histopatolojik olarak, visfatin ve TNF-α antikorları kullanılarak immünohistokimyasal olarak değerlendirilmiştir. Bulgular: Kurşun asetat uygulaması, belirgin ödem, epitel dejenerasyonu, muskularis mukozaya kadar uzanan erozyon, vasküler konjesyon ve yoğun inflamatuvar infiltrasyona neden olmuştur (p<0.001). Buna karşın, naringin tedavisi bu hasar parametrelerinde anlamlı azalma sağlamış, mide mukozasının histolojik bütünlüğünü korumuştur. Ayrıca, kurşun asetat grubunda artan visfatin ve TNF-α immünreaktivitesi, naringin uygulamasıyla belirgin biçimde azalmıştır (p<0.05). Sonuç: Naringin, kurşun asetatın neden olduğu gastrik mukozal hasarı yapısal bütünlüğü koruyarak ve inflamatuvar yanıtı baskılayarak önlemiştir. Bulgular, naringinin inflamatuvar yanıtla ilişkili belirteçler üzerindeki düzenleyici etkileri ve histolojik bulgular ışığında, gastrik doku bütünlüğünün korunmasına katkı sağlayabileceğini düşündürmektedir. Naringin, ağır metal kaynaklı gastrointestinal toksisitelerde koruyucu veya tamamlayıcı bir farmakolojik ajan olarak değerlendirilebilir.

Anahtar Kelimeler

• Naringin
• Kurşun asetat
• Gastrik mukozal hasar
• Visfatin
• TNF-α

Determination of the potential protective effects of naringin on lead acetate–induced gastric injury through visfatin and TNF-α immunoreactivity

Öz

Aim: This study aimed to investigate the protective potential of naringin, a natural flavonoid with potent antioxidant and anti-inflammatory properties, against lead acetate-induced gastric mucosal injury in rats. Lead toxicity disrupts gastric morphology through oxidative stress and excessive inflammatory activation. Therefore, the present research evaluated whether naringin could preserve gastric integrity by modulating inflammation and cellular stress responses. Method: Twenty-eight adult male Wistar albino rats were randomly divided into four groups: control, naringin (40 mg/kg), lead acetate (500 ppm), and lead acetate+naringin. Treatments were administered for 30 consecutive days by oral gavage and in drinking water. At the end of the experiment, gastric tissues were collected for histopathological examination using Hematoxylin–Eosin staining and for immunohistochemical assessment of visfatin and TNF-α expression. Results: Lead acetate exposure caused severe gastric mucosal alterations, including edema, epithelial cell degeneration, erosion extending to the muscularis mucosa, vascular congestion, and intense inflammatory cell infiltration (p<0.001). In contrast, naringin treatment significantly alleviated these pathological changes, maintaining tissue morphology close to that of the control group. Moreover, visfatin and TNF-α immunoreactivity levels were markedly increased in the lead acetate group but significantly decreased in the lead acetate+naringin group (p<0.05), indicating a strong anti-inflammatory response. Conclusion: Naringin demonstrated significant gastroprotective effects against lead-induced mucosal injury by preserving histological integrity and suppressing pro-inflammatory cytokine expression. The findings suggest that naringin may help preserve gastric tissue integrity by regulating inflammatory markers and may be considered a protective or adjunctive agent in heavy metal–induced gastrointestinal toxicities.

Anahtar Kelimeler

• Naringin
• Lead acetate
• Gastric mucosal injury
• Visfatin
• TNF-α

Kaynakça

1. Reis MF, Sampaio C, Brantes A, Aniceto P, Melim M, Cardoso L, et al. Human exposure to heavy metals in the vicinity of Portuguese solid waste incinerators: Part 3: biomonitoring of Pb in blood of children under the age of 6 years. Int J Hyg Environ Health. 2007;210(3-4):455-459.
2. Toplan S, Ozcelik D, Gulyasar T, Akyolcu MC. Changes in hemorheological parameters due to lead exposure in female rats. J Trace Elem Med Biol. 2004;18(2):179-182.
3. Tyroler HA. Epidemiology of hypertension as a public health problem: an overview as background for evaluation of blood lead-blood pressure relationship. Environ Health Perspect. 1988;78:3-7.
4. Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect. 1991;91:71-75.
5. Walsh CT, Ryden EB. The effect of chronic ingestion of lead on gastrointestinal transit in rats. Toxicol Appl Pharmacol. 1984;75(3):485-495.
6. Ryden EB, Walsh CT. The effect of lead on cholinergic contractile function in the rat forestomach. Toxicology. 1987;45(1):65-78.
7. Vahedian Z, Nabavizadeh F, Keshavarz M, Vahedian J, Mirershadi F. Lead exposure changes gastric acid secretion in rat: role of nitric oxide (NO). Acta Med Iran. 2011;49(1):3-8.
8. Majka SM, Barak Y, Klemm DJ. Concise review: adipocyte origins: weighing the possibilities. Stem Cells. 2011;29(7):1034-1040.

9. Sommer G, Garten A, Petzold S, Beck-Sickinger AG, Blüher M, Stumvoll M, et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond). 2008;115(1):13-23.
10. Busso N, Karababa M, Nobile M, Rolaz A, Van Gool F, Galli M, et al. Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One. 2008;3(5):e2267.
11. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol. 2007;178(3):1748-1758.
12. Chen L, Teng H, Jia Z, Battino M, Miron A, Yu Z, Cao H, Xiao J. Intracellular signaling pathways of inflammation modulated by dietary flavonoids: The most recent evidence. Crit Rev Food Sci Nutr. 2018;58:2908-2924.
13. Chen L, Teng H, Xie Z, Cao H, Cheang WS, Skalicka-Woniak K, Georgiev MI, Xiao J. Modifications of dietary flavonoids towards improved bioactivity: An update on structure–activity relationship. Crit Rev Food Sci Nutr. 2018;58:513-527.
14. Tripoli E, La Guardia M, Giammanco S, Di Majo D, Giammanco M. Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review. Food Chem. 2007;104:466-479.
15. Zhang J, Gao W, Liu Z, Zhang Z, Liu C. Systematic analysis of main constituents in rat biological samples after oral administration of the methanol extract of Fructus Aurantii by HPLC-ESI-MS/MS. Iran J Pharm Res. 2014;13:493-503.
16. Chtourou Y, Gargouri B, Kebieche M, Fetoui H. Naringin abrogates cisplatin-induced cognitive deficits and cholinergic dysfunction through the down-regulation of AChE expression and iNOS signaling pathways in hippocampus of aged rats. J Mol Neurosci. 2015;56:349-362.
17. Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans CA. Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochem Biophys Res Commun. 1999;265:410-415.
18. Camargo CA, Gomes-Marcondes MCC, Wutzki NC, Aoyama H. Naringin inhibits tumor growth and reduces interleukin-6 and tumor necrosis factor α levels in rats with Walker 256 carcinosarcoma. Anticancer Res. 2012;32:129-133.
19. Chtourou Y, Aouey B, Aroui S, Kebieche M, Fetoui H. Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat. Chem Biol Interact. 2016;243:1-9.
20. Koc S, Erdogan MA, Erdogan E, Yalcin A, Turk A, Erdogan MM. Protective effect of benfotiamine on methotrexate induced gastric damage in rats. Biotech Histochem. 2021;96(8):586-593.
21. Jangra R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans CA. Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. Biochem Biophys Res Commun. 1999;265(2):410-415.
22. Wang J, Zhang Y, Zhang X, et al. Protective effects of Hizikia fusiforme and Chlorella sp. extracts against lead acetate-induced hepatotoxicity in rats. Fisheries Aquat Sci. 2019;22(1):2.
23. Wallace JL. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself? Physiol Rev. 2008;88(4):1547-1565.
24. Martin MJ, Marhuenda E, Pérez-Guerrero C, Franco JM. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology. 1994;49(3):144–150.
25. Ragab Mousa H, Fahmy Shaheen N. Gastroprotective and healing effect of naringin and quercetin in experimentally induced gastric ulcer by diclofenac sodium in adult male albino rat: a histological and immunohistochemical study. Egypt J Hosp Med. 2023;90(1):213–225.
26. Hambardikar VR, Mandlik DS. Protective effect of naringin ameliorates TNBS-induced colitis in rats via improving antioxidant status and pro-inflammatory cytokines. Immunopharmacol Immunotoxicol. 2022;44(3):373–386.
27. Abas ASM, Sherif MH, Ibrahim S. Effects of naringin and zinc treatment on biochemical, molecular, and histological alterations in stomach and pancreatic tissues of STZ-induced diabetic rats. Adv Biol. 2025;9(4):2400688.
28. Mansour LAH, Elshopakey GE, Abdelhamid FM, Albukhari TA, Almehmadi SJ, Refaat B, et al. Hepatoprotective and neuroprotective effects of naringenin against lead-induced oxidative stress, inflammation, and apoptosis in rats. Biomedicines. 2023;11(4):1080.
29. Alboghobeish S, Mahdavinia M, Zeidooni L, Samimi A, Oroojan AA, Alizadeh S, et al. Efficiency of naringin against testicular toxicity and oxidative stress induced by bisphenol A in rats. Iran J Basic Med Sci. 2019;22(3):315–323.